• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Reimbursing Genetic Counselors in the Clinical Lab

Reimbursing Genetic Counselors in the Clinical Lab

by Michael Schubert, PhD | Jan 22, 2025 | Coding-lca, Essential, Lab Industry Advisor, Reimbursement-lir

Sara Pirzadeh-Miller offers advice on overcoming the reimbursement barriers genetic counselors face in the clinical lab and beyond

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: 2024 Trends in FDA Approvals

Diagnostics Pipeline: 2024 Trends in FDA Approvals

by Rachel Muenz | Jan 6, 2025 | Clinical Diagnostics Insider, FDA-dtet

In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Evolving Regulations and Guidelines in Genetic Testing

Evolving Regulations and Guidelines in Genetic Testing

by Marnie Willman | Nov 25, 2024 | Clinical Diagnostics Insider, FDA-dtet

Understanding the regulatory landscape of genetic and genomic testing, and its impact on clinical practice

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Esophageal Pre-Cancer Testing Gaining Greater Traction

Esophageal Pre-Cancer Testing Gaining Greater Traction

by Ron Shinkman | Oct 29, 2024 | Clinical Diagnostics Insider, FDA-dtet

How three companies are addressing screening challenges with tests that help improve chances of early detection

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Labs in Court: Two EKRA-Related Cases and Some Usual Suspects

Labs in Court: Two EKRA-Related Cases and Some Usual Suspects

by Danielle Sloane, Morgan Tandy | Oct 28, 2024 | Essential, Lab Industry Advisor, Labs in Court

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com